Atlas Trials

Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis

Clinical trial NCT04966559 · UNKNOWN

Trial details

NCT number
NCT04966559
Sponsor
Asbjørn Mohr Drewes
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Pancreatitis, Acute
Start date
2022-01-12
Primary completion
2024-03-30
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.